Lam S - Search Results

1

Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy.

Bazett M, Costa AM, Bosiljcic M, Anderson RM, Alexander MP, Wong SWY, Dhanji S, Chen JM, Pankovich J, Lam S, Sutcliffe S, Gunn H, Kalyan S, Mullins DW. Bazett M, et al. Among authors: lam s. Oncoimmunology. 2017 Nov 27;7(3):e1398875. doi: 10.1080/2162402X.2017.1398875. eCollection 2018. Oncoimmunology. 2017. PMID: 29399400 Free PMC article.

2

CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development.

Melese ES, Franks E, Cederberg RA, Harbourne BT, Shi R, Wadsworth BJ, Collier JL, Halvorsen EC, Johnson F, Luu J, Oh MH, Lam V, Krystal G, Hoover SB, Raffeld M, Simpson RM, Unni AM, Lam WL, Lam S, Abraham N, Bennewith KL, Lockwood WW. Melese ES, et al. Among authors: lam v, lam s, lam wl. Oncoimmunology. 2021 Dec 30;11(1):2010905. doi: 10.1080/2162402X.2021.2010905. eCollection 2022. Oncoimmunology. 2021. PMID: 35481284 Free PMC article.

3

Macrophages, Inflammation, and Lung Cancer.

Conway EM, Pikor LA, Kung SH, Hamilton MJ, Lam S, Lam WL, Bennewith KL. Conway EM, et al. Among authors: lam s, lam wl. Am J Respir Crit Care Med. 2016 Jan 15;193(2):116-30. doi: 10.1164/rccm.201508-1545CI. Am J Respir Crit Care Med. 2016. PMID: 26583808

4

Lung cancer screening.

McWilliams A, Lam S. McWilliams A, et al. Among authors: lam s. Curr Opin Pulm Med. 2005 Jul;11(4):272-7. doi: 10.1097/01.mcp.0000166592.10666.d1. Curr Opin Pulm Med. 2005. PMID: 15928490 Review.

5

The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.

Guan J, Lo M, Dockery P, Mahon S, Karp CM, Buckley AR, Lam S, Gout PW, Wang YZ. Guan J, et al. Among authors: lam s. Cancer Chemother Pharmacol. 2009 Aug;64(3):463-72. doi: 10.1007/s00280-008-0894-4. Epub 2008 Dec 24. Cancer Chemother Pharmacol. 2009. PMID: 19104813

6

Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection.

Yee J, Sadar MD, Sin DD, Kuzyk M, Xing L, Kondra J, McWilliams A, Man SF, Lam S. Yee J, et al. Among authors: lam s. J Clin Oncol. 2009 Jun 10;27(17):2787-92. doi: 10.1200/JCO.2008.19.4233. Epub 2009 May 4. J Clin Oncol. 2009. PMID: 19414677 Free PMC article.

7

Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.

Dong X, Lin D, Low C, Vucic EA, English JC, Yee J, Murray N, Lam WL, Ling V, Lam S, Gout PW, Wang Y. Dong X, et al. Among authors: lam s, lam wl. J Thorac Oncol. 2013 Feb;8(2):161-70. doi: 10.1097/JTO.0b013e31827d5237. J Thorac Oncol. 2013. PMID: 23287853 Free article.

8

Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrence.

Enfield KSS, Martin SD, Marshall EA, Kung SHY, Gallagher P, Milne K, Chen Z, Nelson BH, Lam S, English JC, MacAulay CE, Lam WL, Guillaud M. Enfield KSS, et al. Among authors: lam s, lam wl. J Immunother Cancer. 2019 Jan 16;7(1):13. doi: 10.1186/s40425-018-0488-6. J Immunother Cancer. 2019. PMID: 30651131 Free PMC article.

9

Lung Cancer Screening in Never-Smokers.

Lam S. Lam S. J Thorac Oncol. 2019 Mar;14(3):336-337. doi: 10.1016/j.jtho.2018.12.019. J Thorac Oncol. 2019. PMID: 30782380 Free article. No abstract available.

10

PD-L1 testing on the EBUS-FNA cytology specimens of non-small cell lung cancer.

Wang G, Ionescu DN, Lee CH, Hiruki T, Myers R, Shaipanich T, Lam S, Melosky B, Zhou C. Wang G, et al. Among authors: lam s. Lung Cancer. 2019 Oct;136:1-5. doi: 10.1016/j.lungcan.2019.07.033. Epub 2019 Aug 1. Lung Cancer. 2019. PMID: 31421256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,127 results

Search Page